Literature DB >> 2806355

Prognosis and morbidity after total thyroidectomy for papillary, follicular and medullary thyroid cancer.

J F Hamming1, C J Van de Velde, B M Goslings, L J Schelfhout, G J Fleuren, J Hermans, A Zwaveling.   

Abstract

The prognosis and the morbidity results after total thyroidectomy are reported for 148 patients with differentiated thyroid cancer. Ninety-two patients (62%) had papillary cancer, 27 (18%) had follicular cancer and 29 (20%) had medullary cancer. In the latter group, 16 patients had no clinical signs of a tumour and underwent total thyroidectomy after elevated calcitonin levels were found in a family screening programme. The mean follow-up period was 9.7 years in the present series. The 5- and 10-year overall survival in the patient group with papillary cancer was 97% and 95% respectively, in the group with follicular cancer it was 78% and 50% respectively and in the group with medullary cancer it was 91% and 82% respectively. Significantly associated with reduced disease-free survival were: extrathyroidal growth (P less than 0.0001), distant metastases at diagnosis (P less than 0.0001), follicular histology (P less than 0.0001), age over 40 (P less than 0.001) and male sex (P less than 0.05). In patients with papillary cancer, recurrences were in most cases located in the neck, while recurrences at distant sites were encountered more frequently in patients with follicular or medullary cancer. Accidental permanent unilateral recurrent laryngeal nerve palsy were registered in 1.4% of the nerves at risk; all on the side of the tumour. Permanent hypoparathyroidism was present in 4% of the patients.

Entities:  

Mesh:

Year:  1989        PMID: 2806355     DOI: 10.1016/0277-5379(89)90079-5

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  3 in total

1.  Recurrent differentiated thyroid cancer: to cut or burn.

Authors:  Roberto Cirocchi; Stefano Trastulli; Alessandro Sanguinetti; Lorenzo Cattorini; Piero Covarelli; Domenico Giannotti; Giorgio Di Rocco; Fabio Rondelli; Francesco Barberini; Carlo Boselli; Alberto Santoro; Nino Gullà; Adriano Redler; Nicola Avenia
Journal:  World J Surg Oncol       Date:  2011-08-12       Impact factor: 2.754

2.  [Prognostic factors and the effect of radiotherapy in the treatment of differentiated thyroid carcinomas].

Authors:  I A Adamietz; M S Schiemann; J G Petkauskas; F Schemmann; H D Böttcher
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

3.  Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data.

Authors:  Michael Carlberg; Lena Hedendahl; Mikko Ahonen; Tarmo Koppel; Lennart Hardell
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.